Correlation between decrease in vasostatin-2 level and severity of coronary heart disease

苏倩,王晓群,陆林,张瑞岩,沈卫峰,张凤如
DOI: https://doi.org/10.3969/j.issn.1673-6087.2013.04.008
2013-01-01
Abstract:Objective To investigate the correlation between vasostatin-2(VS-2),a peptide fragment derived from chromogranin A,and severity of coronary heart disease(CHD).Methods Five hundred and fifty four patients with CHD(luminal diameter narrowing ≥50%) were enrolled in this study,and 281 subjects with normal coronary arteries or nonsignificant CHD(luminal diameter narrowing <30%) were served as controls.Enzyme-linked immunosorbent assay(ELISA) was performed to determine serum levels of VS-2,high-sensitivity C-reactive protein(hs-CRP),soluble intercellular adhesion molecule 1(sICAM-1) and soluble vascular cell adhesion molecule 1(sVCAM-1).Results Compared with control group,serum VS-2 level was significantly lower in CHD patients [(4.45±2.64) μg/L vs(5.82±3.22) μg/L,P<0.001],hsCRP,sICAM-1 and sVCAM-1 level was significantly higher in CHD patients(all P<0.001).VS-2 was negatively correlated with number of diseased coronary arteries(r=-0.206,P<0.05).Multivariable logistic regression analysis demonstrated that decreased vasostatin-2 level is an independent risk factor for CHD(P <0.05).Conclusions Serum VS-2 level is significantly lower in CHD patients and is correlated negatively with the severity of CHD.
What problem does this paper attempt to address?